Alfa. de Full Year 2024 Earnings: Misses Expectations

Simply Wall St
BMV:ALFA A

Alfa. de (BMV:ALFAA) Full Year 2024 Results

Key Financial Results

  • Revenue: Mex$163.2b (up 6.6% from FY 2023).
  • Net loss: Mex$1.21b (loss narrowed by 73% from FY 2023).
  • Mex$0.24 loss per share (improved from Mex$0.92 loss in FY 2023).

AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early.

revenue-and-expenses-breakdown
BMV:ALFA A Revenue and Expenses Breakdown March 28th 2025

All figures shown in the chart above are for the trailing 12 month (TTM) period

Alfa. de Revenues and Earnings Miss Expectations

Revenue missed analyst estimates by 48%. Earnings per share (EPS) was also behind analyst expectations.

The primary driver behind last 12 months revenue was the Sigma segment contributing a total revenue of Mex$160.9b (99% of total revenue). Notably, cost of sales worth Mex$112.0b amounted to 69% of total revenue thereby underscoring the impact on earnings. The largest operating expense was Sales & Marketing costs, amounting to Mex$28.0b (53% of total expenses). Explore how ALFA A's revenue and expenses shape its earnings.

Looking ahead, revenue is forecast to grow 6.2% p.a. on average during the next 3 years, compared to a 37% decline forecast for the Industrials industry in South America.

Performance of the market in Mexico.

The company's shares are down 1.1% from a week ago.

Risk Analysis

You should learn about the 2 warning signs we've spotted with Alfa. de (including 1 which shouldn't be ignored).

Valuation is complex, but we're here to simplify it.

Discover if Alfa. de might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.

Access Free Analysis

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.